Table of Contents
ISRN Endocrinology
Volume 2014 (2014), Article ID 689260, 5 pages
http://dx.doi.org/10.1155/2014/689260
Research Article

The Response of Circulating Leptin Levels to Exercise Stress Testing in Subjects Diagnosed with Metabolic Syndrome

1University of Medicine and Pharmacy, 4 Pasteur Street, Cluj-Napoca, Romania
2Rehabilitation Hospital, 46-50 Viilor Street, 400437 Cluj-Napoca, Romania
3Faculty of Economics and Business Administration, “Babes-Bolyai” University, Strada Teodor Mihali, No. 58-60, 400591 Cluj-Napoca, Romania

Received 11 October 2013; Accepted 11 November 2013; Published 28 January 2014

Academic Editors: M. Hedayati, J. Nedvidkova, and K. Yamagami

Copyright © 2014 Dana Pop et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. G. M. M. Alberti and P. Zimmet, “Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation,” Diabetic Medicine, vol. 23, no. 5, pp. 469–480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Wang, W. Luo, and D. T. Eitzman, “Leptin in thrombosis and atherosclerosis,” Current Pharmaceutical Design, 2013. View at Google Scholar
  3. V. DeClercq, J. E. Enns, A. Yeganeh, C. G. Taylor, and P. Zahradka, “Modulation of cardiovascular function by adipokines,” Cardiovascular and Hematological Disorders, vol. 13, no. 1, pp. 59–72, 2013. View at Publisher · View at Google Scholar
  4. H. S. Mattu and H. S. Randeva, “Role of adipokines in cardiovascular disease,” Journal of Endocrinology, vol. 216, no. 1, pp. T17–T36, 2013. View at Publisher · View at Google Scholar
  5. S. G. Wannamethee, J. Tchernova, P. Whincup et al., “Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease,” Atherosclerosis, vol. 191, no. 2, pp. 418–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. J. Lavie, T. S. Church, R. V. Milani, and C. P. Earnest, “Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation,” Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 31, no. 3, pp. 137–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. T. H. Luk, Y. L. Dai, C. W. Siu et al., “Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial,” European Journal of Preventive Cardiology, vol. 19, no. 4, pp. 830–839, 2012. View at Publisher · View at Google Scholar
  8. D. Zdrenghea, Recuperarea şi Prevenţia Cardiovasculară, Clusium, Cluj-Napoca, Romania, 2008.
  9. M. W. Hulver and J. A. Houmard, “Plasma leptin and exercise: recent findings,” Sports Medicine, vol. 33, no. 7, pp. 473–482, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. R. R. Kraemer, L. G. Johnson, R. Haltom et al., “Serum leptin concentrations in response to acute exercise in postmenopausal women with and without hormone replacement therapy,” Proceedings of the Society for Experimental Biology and Medicine, vol. 221, no. 3, pp. 171–177, 1999. View at Google Scholar · View at Scopus
  11. L. Pérusse, G. Collier, J. Gagnon et al., “Acute and chronic effects of exercise on leptin levels in humans,” Journal of Applied Physiology, vol. 83, no. 1, pp. 5–10, 1997. View at Google Scholar · View at Scopus
  12. J. A. Houmard, J. H. Cox, P. S. MacLean, and H. A. Barakat, “Effect of short-term exercise training on leptin and insulin action,” Metabolism: Clinical and Experimental, vol. 49, no. 7, pp. 858–861, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Leal-Cerro, P. P. Garcia-Luna, R. Astorga et al., “Serum leptin levels in male marathon athletes before and after the marathon run,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 7, pp. 2376–2379, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Landt, G. M. Lawson, J. M. Helgeson et al., “Prolonged exercise decreases serum leptin concentrations,” Metabolism, vol. 46, no. 10, pp. 1109–1112, 1997. View at Publisher · View at Google Scholar
  15. M. Duclos, J.-B. Corcuff, A. Ruffie, P. Roger, and G. Manier, “Rapid leptin decrease in immediate post-exercise recovery,” Clinical Endocrinology, vol. 50, no. 3, pp. 337–342, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. J. L. Olive and G. D. Miller, “Differential effects of maximal- and moderate-intensity runs on plasma leptin in healthy trained subjects,” Nutrition, vol. 17, no. 5, pp. 365–369, 2001. View at Google Scholar
  17. N. Lakhdar, H. Ben Saad, M. Denguezli et al., “Effects of intense cycling training on plasma leptin and adiponectin and its relation to insulin resistance,” Neuroendocrinology Letters, vol. 34, no. 3, pp. 229–235, 2013. View at Google Scholar
  18. O. Ozcelik, H. Celik, A. Ayar, S. Serhatlioglu, and H. Kelestimur, “Investigation of the influence of training status on the relationship between the acute exercise and serum leptin levels in obese females,” Neuroendocrinology Letters, vol. 25, no. 5, pp. 381–385, 2004. View at Google Scholar
  19. A. M. Wallace, A. D. McMahon, C. J. Packard et al., “Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS),” Circulation, vol. 104, pp. 3052–3056, 2001. View at Google Scholar
  20. P. Piatti, C. Di Mario, L. D. Monti et al., “Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting,” Circulation, vol. 108, no. 17, pp. 2074–2081, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Söderberg, B. Ahrén, B. Stegmayr et al., “Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort,” Stroke, vol. 30, no. 2, pp. 328–337, 1999. View at Google Scholar · View at Scopus
  22. A. Qasim, N. N. Mehta, M. G. Tadesse et al., “Adipokines, insulin resistance, and coronary artery calcification,” Journal of the American College of Cardiology, vol. 52, no. 3, pp. 231–236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Kwon and J. E. Pessin, “Adipokines mediate inflammation and insulin resistance,” Frontiers in Endocrinology, vol. 4, article 71, 2013. View at Publisher · View at Google Scholar
  24. D. C. W. Lau, B. Dhillon, H. Yan, P. E. Szmitko, and S. Verma, “Adipokines: molecular links between obesity and atheroslcerosis,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 288, no. 5, pp. H2031–H2041, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Gustafson, “Adipose tissue, inflammation and atherosclerosis,” Journal of Atherosclerosis and Thrombosis, vol. 17, no. 4, pp. 332–341, 2010. View at Google Scholar · View at Scopus
  26. D. Pop, D. Zdrenghea, L. Stanca, G. Bodisz, D. Petrovai, and B. Borz, “Adiponectin and leptin levels correlate with body mass index and lipid fractions but not with disturbances of glucose metabolism,” Acta Endocrinologica, vol. 5, no. 3, pp. 329–335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Iribarren, G. Husson, A. S. Go et al., “Plasma leptin levels and coronary artery calcification in older adults,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 729–732, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. G. F. Fletcher, G. J. Balady, E. A. Amsterdam et al., “Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association,” Circulation, vol. 104, no. 14, pp. 1694–1740, 2001. View at Google Scholar · View at Scopus